Prodrug approach is a promising way of overcoming gastrotoxicity associated with long term oral use of NSAIDs like ibuprofen. The candidature of benzyl ester prodrug of ibuprofen was examined to assess its ability to reduce gastrotoxicity without affecting pharmacological response. It gave highly promising activity profile in established animal models like carrageenan induced rat paw oedema and acetic acid induced writhing reflex assay. The effect of physicochemical properties like aqueous solubility, octanol-water partition coefficient, hydrolysis kinetics in human plasma and simulated gastric fluid, on activity profile has been investigated.
Delphinium denudatum Wall. (Ranunculaceae) is an indigenous medicinal herb popularly known as ‘Jadwar ’widely used in traditional Unani system of medicine for the treatment of a variety of human ailments including epilepsy. In order to increase the bioavailability, the nanophytosome of the Delphinium denudatum root aqueous fraction (DNP) was prepared, characterized and evaluated.
Phytoconstituents have been used in medicine since ancient times due to their various pharmacological actions. Inspite having excellent bio-activity of plant extract and their phytoconstituents in vitro they have no in vivo actions due to their poor lipid solubility or inappropriate molecular size or both, which results in their poor absorption andlower bioavailability. Phytosomes are the novel formulation technology which helps to overcome these problems.Phytosomes are produced by a process whereby a standardized plant extract or its constituents are bound to phospholipids; mainly phosphotidylcholine, producing a lipid compatible complex. The phytosome technology has been applied over many popular herbal drugs such as Ginko biloba, hawthorn, olive oil, grape seed, green tea and ginseng. This article reviews the recent trends in phytosomes drug delivery.
This study was aimed to develop chitosan coupled lipid nanoparticle (Ch-Ptx-Lip), where immunomodulatory activity of chitosan and chemotherapeutic effect of paclitaxel can synergistically enhance efficacy of this novel drug delivery system. Particle size, zeta potential and % Entrapment Efficiency (%EE) of Ch-Ptx-Lip was found to be 113.3 +/- 4.5 nm (PDI: 0.38), (+)35.7 +/- 2.9 mV and 96.4 +/- 1.8% respectively. Morphological evaluation of these particles by TEM shows circular bilayer structure along with outer polymer layers. Ch-Ptx-Lip showed significantly enhanced cytotoxicity (p < 0.05) compared with marketed formulation (Ptx Solution) and Ptx-Lip when evaluated in-vitro by MTT assay on MCF-7 cell lines. Improved efficacy with lower dose of drug can be a new strategy against cancer with minimum side effects and shorter treatment duration.
Through out the decades, biotechnology has emerged as research area which requires the understanding of the biological intricacies of nature. Much of the scientific knowledge has been imparted to transfer beneficial genetic traits from one species to another to enhance or protect an organism. In the field of medicine, these tasks have ranged from the production of proteins, such as insulin, to selective targeting and binding of specific cell types. Since the discovery in the year 1800 that the human body is composed of cells and proteins that are susceptible to infection but can also combat pathogenic microbes, the perceived battlefield has challenged our imagination to develop biopharmaceuticals – biologically based therapeutic products . As we enter the information age, the presence of excessive amount of biologic and genetic data, coupled with exponential growth in computing power, mean that the rate of developing novel biopharmaceuticals is not at all limited by the ability to identify targets and clone macromolecules. But after post GATT period, this research area has faced a lot of restrictions by the government to follow the patent protection of these biologically engineered products of plant or human cell origin. Thus, biotechnology which is usually defined as any technique that uses living organisms or substances from organisms to make or modify a product, to improve plants or animals or to develop microorganisms for specific uses, is facing serious constraints like lack of skilled human resources, funds to bear the cost of these projects, the sophisticated infrastructure and facilities and stringent government laws.
Key words: Biotechnology, patents, biomodulation, tissue.